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Abstract
Background: Chronic kidney disease (CKD) is increasingly being recognized as an emerging public health problem in
India. However, community based estimates of low glomerular filtration rate (GFR) and proteinuria are few. Validity of
traditional serum creatinine based GFR estimating equations in South Asian subjects is also debatable. We intended to
estimate and compare the prevalence of low GFR, proteinuria and associated risk factors in North India using Cockcroft-
Gault (CG) and Modification of Diet In Renal Disease (MDRD) equation.
Methods: A community based, cross-sectional study involving multistage random cluster sampling was done in Delhi
and its surrounding regions. Adults ≥ 20 years were surveyed. CG and MDRD equations were used to estimate GFR
(eGFR). Low GFR was defined as eGFR < 60 ml/min/1.73 m2. Proteinuria (≥ 1+) was assessed using visually read dipsticks.
Odds ratios, crude and adjusted, were calculated to ascertain associations between renal impairment, proteinuria and
risk factors.
Results: The study population had 3,155 males and 2,097 females. The mean age for low eGFR subjects was 54 years.
The unstandardized prevalence of low eGFR was 13.3% by CG equation and 4.2% by MDRD equation. The prevalence
estimates of MDRD equation were lower across gender and age groups when compared with CG equation estimates.
There was a strong correlation but poor agreement between GFR estimates of two equations. The survey population
had a 2.25% prevalence of proteinuria. In a multivariate logistic regression analysis; age above 60 years, female gender,
low educational status, increased waist circumference, hypertension and diabetes were associated with low eGFR. Similar
factors were also associated with proteinuria. Only 3.3% of subjects with renal impairment were aware of their disease.
Conclusion: The prevalence of low eGFR in North India is probably higher than previous estimates. There is a significant
difference between GFR estimates derived from CG and MDRD equations. These equations may not be useful in
epidemiological research. GFR estimating equations validated for South Asian populations are needed before reliable
estimates of CKD prevalence can be obtained. Till then, primary prevention and management targeted at CKD risk
factors must play a critical role in controlling rising CKD magnitude. Cost-benefit analysis of targeted screening programs
is needed.
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Background
Economic development and changing lifestyle habits are
increasingly having a significant impact on the public
health scenario of tropical nations. This epidemiological
transition has necessitated reconsideration of public
health policies. Whilst the focus previously was entirely
on communicable diseases, mostly infectious, the increas-
ing prevalence of non-communicable diseases and their
risk factors is worrisome. Considering the monetary con-
straints and the national and global commitments to limit
or eradicate infectious diseases, the increasing burden of
lifestyle disorders is bound to introduce resource crunch-
ing on the health sector of these economies. One such sit-
uation being faced now by India and other nations is the
increasing prevalence of chronic kidney disease (CKD).
India at present has the world's largest population of dia-
betics [1] and obesity has long been recognized as an
emerging epidemic. The CURES cohort suggested that
every fifth person in India is hypertensive [2]. Considering
the high prevalence of CKD risk factors it has long been
presumed that CKD represents a major public health
problem in India, at least in urban cities. However, in view
of an overburdened health setup and absence of national
registries, the true magnitude of CKD has largely been
controversial. Only two population-based studies estimat-
ing CKD prevalence in India are available [3-5]. But these
studies either used crude criteria for defining CKD or did
not cover the entire spectrum of population. The issue of
obtaining an accurate estimate of CKD prevalence is fur-
ther limited by lack of glomerular filtration rate (GFR)
estimating equations validated for Indian population.
Majority of these equations have been derived predomi-
nantly from Caucasian populations and may not be relia-
ble and accurate in Indian context [6,7]. Cockcroft-Gault
(CG) and Modification of Diet in Renal Disease (MDRD)
equations have been used worldwide in epidemiological
studies on CKD. However, till date no community-based
study has compared GFR estimates derived from these two
equations in Indian population.
In light of the limitations of above studies and the amena-
bility of limiting CKD costs with early detection and pri-
mary prevention, we conducted this study. We intended
to estimate the prevalence of low glomerular filtration
rate, proteinuria and CKD associated risk factors in a pop-
ulation based cross-sectional survey in North India.
Methods
Study design
The study was conducted in Delhi and adjoining regions.
Delhi, being the only metropolitan city in North India,
has population representation from almost every state.
While majority of Delhi can be classified as urban or per-
iurban, the surrounding regions are primarily rural. Thus
we were able to evaluate the entire socioeconomic spec-
trum of population. The study was designed as a cross-sec-
tional survey and involved multistage random cluster
sampling. The study was funded by a government-based
organization (UGC; University Grants Commission) and
was conducted from April 2005 to December 2007 after
approval by the ethical committee of Maulana Azad Med-
ical College.
Subjects and Sample size
Delhi and its adjoining regions have a population of 13 ×
106 with 55% of population aged 20 years or above. To
ensure an adequate representation, the entire population
was divided into clusters and sampling was done propor-
tionate to cluster population. Only adults (≥ 20 years)
were included. We anticipated the prevalence of low eGFR
to be 5–10% based on estimates of recent epidemiological
studies from Asian and African countries [8-10]. We
intended to estimate prevalence within 1 percentage point
(d = 0.01) of true value with 95% confidence. Thus the
required sample size, for multistage random cluster sam-
pling, was 6,914. In the field, local health workers facili-
tated the interaction of surveyors with community.
Selected patients were invited to visit local health center
where detailed evaluation was done.
Method
A pre-structured and validated questionnaire was admin-
istered to all participants who presented for health
checkup. The questionnaire collected information about
demographics, lifestyle habits and CKD risk factors.
Anthropometric parameters were assessed using standard-
ized techniques. Body weight and height were measured
in light clothes without footwear. Every participant under-
went a blood pressure measurement by two physicians at
an interval of 10 minutes and the mean of two measure-
ments was finally recorded. A spot urinary protein was
assessed using dipsticks. 5 ml of fasting venous blood
sample was taken for assessing biochemical variables. All
participants gave informed consent.
Serum creatinine was estimated using modified Jaffe's
method on a Hitachi 911 auto analyzer. All samples were
analyzed in the same laboratory on same equipment
throughout the duration of study. Twice daily quality con-
trol checks were done. The upper limit for normal serum
creatinine levels was 1.2 mg/dl. We however did not
standardize the serum creatinine measurements to those
used in Modification of Diet in Renal Disease (MDRD)
equation.
Evaluation criteria
All subjects were assessed for biochemical and clinical var-
iables using established guidelines and norms.BMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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Hypertension (HTN)
Hypertension was defined as per JNC-7 guidelines [11].
Systolic blood pressure (SBP) ≥ 140 mmHg and diastolic
blood pressure (DBP) ≥ 90 mmHg were used as cutoffs.
Patients taking anti-hypertensive drugs were also
included, even if they had blood pressure values lower
than cutoff. However, no adjustments in cutoff values
were made for diabetic status. Also we did not stratify
HTN by severity or by anti-hypertensive drug intake.
Diabetes mellitus (DM)
Known diabetics on treatment were considered diabetic
regardless of their glycemic control. For others, a 12-hour
fasting blood sugar level of ≥ 126 mg/dl was used as cutoff
[12].
Proteinuria
Proteinuria was estimated using visually read dipsticks
(Teco diagnostics, USA). None and trace urinary protein
were classified as no proteinuria and rest (1+, 2+ and 3+)
as proteinuria. Women having menstrual periods were
studied remote from their periods. Pregnant women and
subjects with active urinary tract infections were excluded.
Renal impairment
The glomerular filtration rate (GFR) was estimated using
Cockcroft-Gault (CG) formula corrected for sex and body
surface area (BSA). Use of BSA corrected CG equation ena-
bled direct comparisons with GFR estimates of Modifica-
tion of Diet in Renal Disease (MDRD) equation. We
preferred to use CG-GFR estimates over CG-creatinine
clearance estimates, as CG-GFR equation is better suited
to estimate subnormal GFR in Indian population besides
being corrected for renal tubular secretion of creatinine
[7].
CG/BSA formula
Creatinine clearance (ml/min/1.73 m2) = 
[(140-age)*(weight)/(serum creatinine*72*BSA/1.73)]
*(0.85 if female) (1)
BSA (m2) = 0.20247*(height in meters)0.725*
(weight in kg)0.425
CG-GFR estimate (ml/min/1.73 m2) = 
0.84* (creatinine clearance by equation 1)
We also used abbreviated four variable Modification of
Diet in Renal Disease (MDRD) equation to estimate GFR.
Since prevalence estimates of CKD are dependent on the
nature of GFR estimating equations, it enabled us to com-
pare prevalence estimates obtained from two equations.
MDRD-GFR (ml/min/1.73 m2) = 
186*(serum creatinine)-1.154*(age)-0.203*
(0.742 if female) (2)
The estimated GFR (eGFR) was then used to classify sub-
jects into Kidney Disease Outcomes Quality Initiative (K/
DOQI) stages of CKD [13]. Renal impairment was
defined as eGFR less than 60 ml/min/1.73 m2. Thus stage
3, 4 and 5 of KDOQI were grouped as renal impairment.
Obesity
Weight (in kilograms) and height (in meters) were used to
calculate body mass index (BMI). The classification of
BMI, as recommended by WHO, was employed [14]. BMI
≥ 25 kg/m2 was used as the cutoff for obesity [15]. Addi-
tionally, waist circumference (WC) was used to assess
body fat distribution. WC was measured using smallest
circumference between lower ribs and iliac crests. The
mean of two measurements was taken as the final value. A
WC > 85 cm and > 80 cm was used as the cutoff for men
and women respectively [15].
Smoking and Alcohol intake
Smoking was dichotomized as current smokers or not.
Alcohol intake was dichotomized on basis of intake fre-
quency, at least weekly against monthly or rarely. No
attempt was made to quantify amount of smoking (packs
per day) or alcohol intake.
Statistical Analysis
Results were expressed as absolute numbers, proportions,
means with standard deviations or medians with range.
Nominal variables were analyzed for associations using
Chi-square test and crude (unadjusted) odds ratio were
calculated where appropriate. Interval variables were ana-
lyzed using t-test for normally distributed variables and
Wilcoxon's rank sum test for non-normal distributions.
Multivariate logistic regression models were framed
adjusting for all variables and significant two-way interac-
tions between variables. Backward selection was used to
drop insignificant terms. All statistical tests were done
using SPSS software (SPSS Inc., Chicago, IL, USA; version
15).p < 0.05 was taken as significant.
Results
A total of 5,563 subjects were surveyed over the duration
of study. 311 (5.6%) subjects were excluded because they
refused to participate. Thus effectively we had 5,252 sub-
jects. 60% of these (3,155) were men and 40% (2,097)
women. The desired sample size could not be achieved
due to funding constraints. Our study population charac-
teristics were similar to those of census population of
Delhi, especially in terms of distribution across age groups
and gender (data not shown).
Prevalence of low glomerular filtration rate
K/DOQI guidelines were used for staging estimated GFR
(eGFR). Table 1 lists the prevalence of stage 3–5 of eGFR
using CG and MDRD equation. The unstandardized prev-
alence for low eGFR in our study population using CG/BMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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BSA equation (Equation 1) was 13.3%. When the popula-
tion was stratified using gender, the prevalence of low
eGFR in males was 11.1% compared to 16.6% of females.
MDRD equation (Equation 2) gave lower estimates; over-
all 4.2%, males 2.7% and females 6.3%. Figure 1 com-
pares the median eGFR and prevalence of low eGFR
obtained using the two equations across age groups and
gender. There was an increasing prevalence of reduced
eGFR across gender with increasing age, regardless of GFR
estimating equation. Also the CG/BSA equation tended to
overestimate CKD prevalence, unlike MDRD equation.
There was a strong correlation between GFR estimates
derived from two equations (r = 0.903, p < 0.001). The
Bland-Altman limits of agreement were broad (Males = -
4.27 to +45.95, Females = -11.88 to +28.82 ml/min/1.73
m2) and MDRD equation tended to overestimate eGFR
when compared to CG equation (Figure 2).
Prevalence of proteinuria
Semi quantitative assessment of proteinuria was done
using visually read dipsticks. In the general population,
2.25% had proteinuria. There was an increasing preva-
lence of proteinuria with age, regardless of gender.
Females aged above 60 years had a higher prevalence of
proteinuria than males (5.76% vs. 3.46% respectively).
Among subjects with proteinuria in the study population
(n  = 118/5,252), 35.6 to 48.3% had reduced eGFR
depending on the GFR estimating equation used. Subjects
with moderately reduced GFR (eGFR 30–59 ml/min/1.73
m2) formed a majority of subjects with low eGFR. In this
subgroup only 6.2–13.6% had evidence of kidney damage
in form of proteinuria. The proportion of subjects with
proteinuria increased as eGFR decreased and almost all
subjects with eGFR < 15 ml/min/1.73 m2 had evidence of
dipstick proteinuria (Table 1).
Prevalence of major CKD risk factors
The study population had 31.2% prevalence of hyperten-
sion (HTN) and 7.3% prevalence of diabetes mellitus
(DM). The prevalence of low eGFR in hypertensives was
17.1% as compared to 11.6% in non-hypertensives. Sim-
ilarly, diabetics had a 19.3% prevalence of low eGFR as
compared to 12.8% of non-diabetics. Prevalence of pro-
teinuria was 3.4 times higher in diabetics than non-dia-
betics (1.9% vs. 6.5%) and 3.8 times higher in
hypertensives than non-hypertensives (1.2% vs. 4.6%).
Table 1: Prevalence of low eGFR and proteinuria in North India.
eGFR (ml/min/1.73 m2)C G / B S A  ( n = 5252) MDRD (n = 5252)
30–59 674 (12.8) 198 (3.8)
15–29 18 (0.3) 9 (0.2)
< 15 6 (0.1) 11 (0.2)
eGFR < 60 ml/min/1.73 m2 698 (13.3) 218 (4.2)
Proteinuria (≥ 1+): prevalence by eGFR strata
30–59 42 (6.2) 27 (13.6)
15–29 9 (50) 5 (55.5)
< 15 6 (100) 10 (90.9)
eGFR < 60 ml/min/1.73 m2 57 (8.2) 42 (19.3)
Proteinuria (≥ 1+): prevalence in total population
Proteinuria (≥ 1+) 118 (2.2) 118 (2.2)
Values are absolute numbers; numbers in parentheses are prevalence (in %). The prevalence estimates of low eGFR by CG/BSA equation were 
higher than MDRD equation. Proportion of subjects with proteinuria increased as eGFR decreased.
eGFR, estimated glomerular filtration rate; CG/BSA, Cockcroft-Gault equation corrected for body surface area; MDRD, modification of diet in 
renal disease equation.BMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
Page 5 of 13
(page number not for citation purposes)
Median eGFR and prevalence of low eGR across age groups in study population Figure 1
Median eGFR and prevalence of low eGR across age groups in study population. The median eGFR progressively 
decreased across age groups and was lower for females than males. Low eGFR was defined as eGFR < 60 ml/min/1.73 m2. Eld-
erly (aged above 60 years) and females had highest prevalence of low eGFR. eGFR, estimated glomerular filtration rate; CG/
BSA, Cockcroft-Gault equation corrected for body surface area; MDRD, modification of diet in renal disease equation.
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MDRD equation overestimated GFR in the study population. The limits of agreement between two equations were broad 
(Males: -4.27 to 45.95 ml/min/1.73 m2, Females: -11.88 to 28.82 ml/min/1.73 m2). The thin dotted line represents a linear fit of 
data point. There was an increase in variance of MDRD eGFR estimates across eGFR range. eGFR, estimated glomerular filtra-
tion rate; CG/BSA, Cockcroft-Gault equation corrected for body surface area; MDRD, modification of diet in renal disease 
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The prevalence of obesity (BMI ≥ 25 kg/m2) was 26.8%
and was comparable across gender.
Characteristics of subjects with low eGFR
Subjects with renal impairment were compared with
those without impairment, stratified according to gender.
Renal impairment (eGFR < 60 ml/min/1.73 m2) was
defined using CG/BSA equation for all further analysis.
The results are tabulated in tables 2 and 3. The mean age
of subjects with low eGFR was 54 years and 39.1% of
those were aged 60 years or above. Males with renal
impairment, as compared to those without, had higher
SBP, DBP and fasting blood glucose levels. Subjects with
low eGFR had higher waist circumference (WC) but lower
BMI than their counterparts. Hemoglobin levels were also
lower in the low eGFR group. There were a higher propor-
tion of diabetics, hypertensives, proteinurics and subjects
with low educational status and sedentary habits in the
low eGFR group. Similar differences for two groups were
found for females also, though there were no significant
differences in hemoglobin levels and physical activity
between the two groups. 28% of male subjects and 5.5%
of females with renal impairment were current smokers,
against 36.3% and 3% of those without. Similarly, 13.4%
of males and 0.6% of females with low eGFR drank alco-
hol at least weekly, against 23% and 0.9% of those with
normal eGFR. 34.8% of all low eGFR subjects gave family
history of at least one amongst: kidney disease, HTN, DM,
myocardial infarction (MI) or stroke. This was signifi-
cantly higher than those without renal impairment (p <
0.001).
Association between low eGFR and risk factors
In unadjusted univariate analysis for males (Table 2),
presence of diabetes (OR; odds ratio 1.92, 95% confi-
dence interval 1.37–2.69) and hypertension (OR 1.62, CI
1.29–2.03) associated with renal impairment. Low educa-
tional status, unsalaried job and non-steroidal anti-
inflammatory drugs (NSAID) intake, independent of
other covariates, also associated with presence of renal
impairment. Males with family history of cardiac/renal
risk factors had at least twice the odds of having low eGFR
than those without such history. Central obesity (as
assessed by WC) also associated with renal impairment
(OR 1.34, CI 1.07–1.67). However, smoking and alcohol
status associated inversely with low eGFR (ORsmoking 0.68,
CI 0.53–0.87; ORalcohol 0.52, CI 0.38–0.71). Males classi-
fied as obese by BMI had less odds of having renal impair-
ment (OR 0.68, CI 0.51–0.89). Subjects with proteinuria
had higher odds of having renal impairment (OR 6.91, CI
4.34–10.99)
Similar associations between renal impairment and cov-
ariates were found for females also. Hypertension (OR
1.63, CI 1.28–2.08), NSAID intake (OR 1.89, CI 1.37–
2.59), low educational status (OR 2.1, CI 1.58–2.79), cen-
tral obesity (OR 1.38, CI 1.10–1.74), presence of pro-
teinuria (OR 6.81, CI 3.63–12.75) and family history of
cardiac/renal risk factors all associated significantly with
renal impairment in univariate analysis. Current smoking
also associated with low eGFR (OR 1.88, CI 1.10–3.23)
but alcohol intake did not associate significantly. How-
ever, unlike males, diabetes did not associate with renal
impairment in unadjusted analysis. Like males, females
with high BMI also had less odds of having renal impair-
ment (OR 0.54, CI 0.40–0.72).
A multivariate logistic regression was done adjusting for
all covariates and two-way interactions between variables.
Variables not contributing significantly were excluded and
model was refitted till all the variables contributed signif-
icantly to explain the probability of renal impairment.
Analysis was done separately for CG and MDRD equation
estimated GFR. The results are tabulated in table 4. The
only significant associations of renal impairment were age
above 60, female gender, low educational status, central
obesity, NSAID intake, hypertension, diabetes and pres-
ence of proteinuria. The risk factor profiles obtained by
CG and MDRD logistic regression models were almost
similar.
Association between proteinuria and risk factors
Age above 60 years, NSAID intake, obesity (as defined by
BMI), central obesity (as assessed by WC), hypertension
and diabetes associated significantly with proteinuria in
univariate analysis (Table 5). After adjusting for con-
founding by other covariates in multivariate logistic
regression only age above 60 years, NSAID intake, central
obesity, hypertension and diabetes effects remained sig-
nificant. Approximately 1 in 10 subjects with diabetes and
hypertension had proteinuria against 1 in 73 for subjects
without diabetes and hypertension.
Awareness of renal impairment
Only 3.3% of subjects with low eGFR were aware of their
renal impairment. Majority of these had eGFR < 30 ml/
min/1.73 m2. Females with renal impairment were less
aware than males (1.4% vs. 5.1%).
Discussion
This is the first community-based study to estimate and
compare the prevalence of low glomerular filtration rate
(low eGFR) in North Indian population using Cockcroft-
Gault (CG) and Modification of Diet In Renal Disease
(MDRD) equation. Our results suggest that burden of
renal impairment may be substantial and there is a strik-
ingly high prevalence of renal and cardiovascular disease
risk factors in North Indian community. The period prev-
alence of renal impairment in our study population aver-
aged from 4.2 to 13.3%, depending on the estimatingBMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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Table 2: Characteristics of males with and without renal impairment (eGFRCG/BSA < 60 ml/min/1.73 m2)
eGFR < 60 ml/min/1.73 m2
(n = 350)
eGFR > 60 ml/min/1.73 m2
(n = 2805)
Crude OR 95% CI
Age (years)* 56.56 (13.52) 38.04 (11.77)
Age above 60 years* 175 (50) 151 (5.4) 17.576 13.47–22.934
Education: Less than primary* 182 (52) 1203 (42.9) 1.443 1.155–1.802
Salaried job* 68 (19.4) 728 (26) 0.688 0.521–0.908
Current smoker* 98 (28) 1017 (36.3) 0.684 0.535–0.874
Current alcohol intake* 47 (13.4) 645 (23) 0.519 0.377–0.715
Exercise (≥ 60 minutes/day) 242 (69.1) 1985 (70.8)
BMI (kg/m2)* 22.42 (3.44) 23.30 (3.69)
Obese by BMI (≥ 25 kg/m2)* 70 (20) 757 (27) 0.676 0.514–0.890
WC (cm)* 83.84 (11.50) 81.12 (10.73)
Obese by WC* 147 (42) 986 (35.2) 1.336 1.066–1.675
Systolic BP (mmHg)* 130 (87–230) 128 (80–200)
Diastolic BP (mmHg)* 84 (57–150) 80 (55–138)
Hypertension* 150 (42.9) 889 (31.7) 1.616 1.289–2.027
Proteinuria* 34 (9.7) 43 (1.5) 6.911 4.343–10.998
Serum creatinine (mg/dl)* 1.2 (0.67–6.30) 0.89 (0.40–1.40)
eGFR CG/BSA* (ml/min/1.73 m2) 53.47 (10.71–59.95) 86.47 (60.02–207.54)
Haemoglobin (g/dl)* 11.23 (1.34) 11.51 (1.31)
Fasting blood glucose (mg/dl)* 98 (63–349) 92 (52–500)
Diabetes mellitus* 47 (13.4) 210 (7.5) 1.917 1.367–2.687
NSAID intake* 41 (11.7) 194 (6.9) 1.786 1.250–2.552
Family history*
CKD, HTN, DM, MI/Stroke
20, 72, 32, 16
(5.7, 20.6, 9.1, 4.6)
43, 261, 127, 37
(1.5, 9.3, 4.5, 1.3)
¶¶
Total cholesterol (mg/dl) 171 (111–272) 171 (111–297)
Values are absolute numbers, means or medians; numbers in parentheses are proportions, standard deviations or range.
* Differences or associations significant at p < 0.05.
¶ Odds ratio ranged from 2.5–3.5 with narrow confidence intervals (p < 0.05).
OR, odds ratio; 95% CI, 95% confidence interval; eGFR, estimated glomerular filtration rate; eGFRCG/BSA, eGFR by Cockcroft-Gault equation 
adjusted for body surface area; BMI, body mass index; WC, waist circumference; BP, blood pressure; NSAID, non steroidal anti inflammatory drugs; 
CKD, chronic kidney disease; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarctionBMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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Table 3: Characteristics of females with and without renal impairment (eGFRCG/BSA < 60 ml/min/1.73 m2)
eGFR < 60 ml/min/1.73 m2
(n = 348)
eGFR > 60 ml/min/1.73 m2
(n = 1749)
Crude OR 95% CI
Age (years)* 51.47 (12.73) 34.26 (10.01)
Age above 60 years* 98 (28.2) 42 (2.4) 15.932 10.84–23.416
Education: Less than primary* 282 (81) 1173 (67.1) 2.098 1.576–2.793
Salaried job* 14 (4) 155 (8.9) 0.431 0.246–0.754
Current smoker* 19 (5.5) 52 (3) 1.885 1.100–3.229
Current alcohol intake 2 (0.6) 15 (0.9)
Exercise (≥ 60 minutes/day) 240 (69) 1252 (71.6)
BMI (kg/m2)* 22.19 (3.41) 23.52 (4.28)
Obese by BMI (≥ 25 kg/m2)* 64 (18.4) 515 (29.5) 0.537 0.402–0.718
WC (cm)* 78.36 (10.24) 77.10 (11.67)
Obese by WC* 156 (44.8) 687 (39.3) 1.382 1.097–1.741
Systolic BP (mmHg)* 130 (100–200) 124 (85–240)
Diastolic BP (mmHg)* 80 (60–114) 80 (50–150)
Hypertension* 130 (37.4) 468 (26.8) 1.631 1.281–2.077
Proteinuria* 23 (6.6) 18 (1.1) 6.806 3.632–12.754
Serum creatinine (mg/dl)* 1.0 (0.6–6.20) 0.8 (0.4–1.30)
eGFR CG/BSA* (ml/min/1.73 m2) 53.77 (8.69–59.99) 81.58 (60.06–186.08)
Haemoglobin (g/dl) 10.79 (1.08) 10.88 (1.07)
Fasting blood glucose (mg/dl)* 95 (55–412) 89 (52–558)
Diabetes 27 (7.8) 99 (5.7)
NSAID intake* 61 (17.5) 177 (10.1) 1.888 1.375–2.592
Family history*
CKD, HTN, DM, MI/Stroke
5, 59, 31, 8
(1.4, 17, 8.9, 2.3)
13, 124, 69, 7
(0.7, 7.1, 3.9, 0.4)
¶¶
Total cholesterol (mg/dl) 168.5 (111–289) 169 (112–312.90)
Values are absolute numbers, means or medians; numbers in parentheses are proportions, standard deviations or range.
* Differences or associations significant at p < 0.05.
¶ Odds ratio ranged from 2.1–2.6 with narrow confidence intervals (p < 0.05).
OR, odds ratio; 95% CI, 95% confidence interval; eGFR, estimated glomerular filtration rate; eGFRCG/BSA, eGFR by Cockcroft-Gault equation 
adjusted for body surface area; BMI, body mass index; WC, waist circumference; BP, blood pressure; NSAID, non steroidal anti inflammatory drugs; 
CKD, chronic kidney disease; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarctionBMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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equation. We are aware of only two community-based
studies assessing prevalence of chronic kidney disease
(CKD) in India. While one placed the prevalence around
0.79% [3], the other estimated it to be 1.39% [5]. The
former study assessed CKD prevalence in an urban setting
of South Delhi using a serum creatinine cutoff of > 1.8
mg% to define renal failure. The latter study assessed CKD
prevalence primarily in a rural setting using MDRD equa-
tion. Both studies had their limitations. Estimates of CKD
based on serum creatinine cutoffs are confounded by
many covariates and are generally considered crude for
epidemiological studies, besides causing significant
underestimation of prevalence [16,17]. The other study
though used MDRD equation, had a major limitation of
being based in a rural population, which is known to have
a significantly lower prevalence of CKD associated risk
Table 4: Association between selected risk factors and renal impairment in the survey population: Multivariate logistic regression.
OR (95% CI)
Model 1#
OR (95% CI)
Model 2#
Age above 60 years 29.489 (21.417–40.604) 13.499 (8.908–20.456)
Gender (Females) 1.529 (1.090–2.145) 3.259 (2.399–4.426)
Education: Less than primary 1.309 (1.013–1.693) ns
Obese by BMI 0.401 (0.310–0.517) ns
Obese by WC 1.338 (1.084–1.652) 1.577 (1.168–2.129)
Hypertension 1.735 (1.388–2.169) 1.370 (1.024–1.833)
Diabetes mellitus 1.513 (1.048–2.184) 2.154 (1.289–3.598)
Proteinuria 16.728 (8.408–33.281) 14.645 (9.167–23.395)
NSAID intake 1.337 (1.010–1.770) ns
Model 1 = Using Cockcroft-Gault equation estimated glomerular filtration rates.
Model 2 = Using Modification of Diet in Renal Disease equation estimated glomerular filtration rates.
# All associations significant at p < 0.05
OR, odds ratio; 95% CI, 95% confidence interval; BMI, body mass index; WC, waist circumference; NSAID, non steroidal anti inflammatory drugs; 
ns, not significant.
Table 5: Risk factors associated with proteinuria in multivariate logistic regression*.
Unadjusted OR 95% CI Adjusted OR 95% CI
Age group
￿ 20–39 Referent Referent Referent Referent
￿ 40–59 2.888 1.900–4.389 1.759 1.133–2.731
￿ Above 60 3.920 2.261–6.794 2.103 1.184–3.735
NSAID intake 3.611 2.359–5.527 2.385 1.532–3.712
Obese by BMI 2.120 1.465–3.068 ns ns
Obese by WC 2.859 1.960–4.169 1.980 1.337–2.934
Hypertension 3.989 2.729–5.830 2.755 1.855–4.091
Diabetes mellitus 3.586 2.277–5.649 2.168 1.349–3.484
* All associations significant at p < 0.05. Proteinuria was defined as ≥ 1+ on dipstick.
OR, odds ratio; 95% CI, 95% confidence interval; BMI, body mass index; WC, waist circumference; NSAID, non steroidal anti inflammatory drugs; 
ns, not significant.BMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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factors [18]. Also in that study only those subjects with
urinary abnormalities or a positive response to a risk fac-
tor assessment questionnaire underwent blood testing,
thus raising concerns of an ascertainment bias. Moreover,
both population-based studies did not comment on dis-
tribution of CKD prevalence across gender and age
groups.
Our study partly overcomes these limitations and gives an
assessment of prevalence of low eGFR in North Indian
community using eGFR cutoffs established by K/DOQI
guidelines. We used both Cockcroft-Gault equation cor-
rected for body surface area (CG/BSA) and Modification
of Diet in Renal Disease (MDRD) equation for estimating
prevalence of renal impairment in our study population.
Though the validity of these equations to estimate GFR in
Indian population has been questioned by few hospital
based studies [6,7] there is no community-based study
which compares the GFR estimates derived from these
two equations. The use of serum creatinine based GFR
estimating equations also ensured crude comparisons
with prevalence data from other countries.
Using CG/BSA equation and a representative population;
our study estimated the prevalence of low eGFR (eGFR <
60 ml/min/1.73 m2) to be 13.3%. With MDRD, the prev-
alence was estimated to 4.2%. These figures are compara-
ble to studies from many other countries, including some
western populations [8,19-23]. The mean age for renal
impairment group in our study was 54 years, which is very
similar to another community-based study in Delhi [3].
Significant impairment of renal function was seen with
increasing age and was worse in females. This is consistent
with studies assessing prevalence of CKD in other nations
[21].
The difference between GFR estimates derived from CG/
BSA and MDRD equation can be explained partly by their
non-validation in Indian population and lack of an
Indian subgroup in the original study populations from
which these equations were derived. For instance, accurate
estimation of GFR by MDRD equation requires coeffi-
cients specific for indigenous population [24]. However
such coefficient or correction factor has not yet been
derived/validated for Indian population. The overestima-
tion of GFR by MDRD equation can also be explained by
its inherent positive bias in Indian subjects [6]. In our
study also MDRD equation had a positive bias and vari-
ance when compared to CG/BSA equation. Though there
was a strong correlation between GFR estimates derived
from two equations, the broad limits of agreement suggest
that determination of true eGFR in a subject is highly
dependent on the equation used.
Diabetes and hypertension are known to play an impor-
tant role in CKD and not surprisingly diabetics (19.3% vs.
12.8%) and hypertensives (17.1% vs. 11.6%) had a
higher prevalence of renal impairment than their healthy
counterparts. Majority of subjects aged 60 years or above
(62.9%) had diabetes or hypertension or both as com-
pared to 36% of subjects below 60 years of age. This, cou-
pled to physiological gradual decline in renal function
with age, may explain the increase in prevalence of low
eGFR with increasing age. These prevalence figures are
comparable to few recent studies assessing prevalence of
HTN and DM in Indian populations [25-28]. However
only 20% of hypertensives and 57% of diabetics were
aware of their diagnostic status.
Family history of kidney disease and cardiac/renal risk fac-
tors significantly associated with renal impairment. This
underscores the influence of genetic factors in CKD. Stud-
ies evaluating risk of developing CKD in relatives of these
"high risk" groups have supported the notion of clustering
of CKD in families and few even recommend regular
screening for CKD in such groups [29,30].
Another interesting observation was the association
between renal impairment and low educational status.
Many studies across nations [19,31] and also studies from
India [32], have found similar associations. Multiple fac-
tors including higher prevalence of obesity and non-com-
municable disease risk factors, poor health seeking
behavior and congenital factors like developmental
endowment with fewer nephrons due to prematurity and
low birth weight, have been suggested as possible expla-
nations.
The inverse association between BMI and renal impair-
ment seems paradoxical. Since BMI assesses the entire
body mass including: central and peripheral fat, muscle
mass and fluid, it is generally believed to be a less sensitive
estimate of obesity in CKD patients [33]. Since it is the
central obesity which determines the cardiovascular and
renal risk, a measure that assesses visceral fat will be pref-
erable in these subjects. Waist circumference (WC) and
waist:hip ratio (WHR) are two such markers. These mark-
ers of central obesity have been shown to be better associ-
ated with of renal and cardiovascular risk than BMI in
longitudinal and cross-sectional studies [34,35]. Indeed
our study shows an association between undesirable WC
and renal impairment. We preferred to use WC over WHR
as WC is more sensitive index of upper body adiposity
than WHR in Indian population [15].
Our study also suggests an inverse association between
renal impairment and smoking and alcohol status. Simi-
lar observations were documented in a cross-sectionalBMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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study in an Australian Aboriginal community [23]. It was
suggested that in populations with low per capita income
cigarette smoking marked relative affluence, which itself
protected against renal disease. A cross-sectional study
from Japan also suggested an inverse association between
current smoking and low eGFR [36]. The possibility of a
survivor bias in cross-sectional design can also explain
this inverse association. It's likely that smokers and alco-
holics die before their renal impairment can be detected
from other causes like cardiovascular events or cirrhosis.
Another possible explanation could be related to change
in lifestyle among subjects aware of their renal impair-
ment status. However, the low awareness of CKD in our
study population makes this hypothesis less plausible.
However, evidence on the contrary is also available in the
literature. Some cross-sectional studies have demon-
strated a positive association between smoking, alcohol
intake and renal impairment [37,38]. This discrepancy in
results could be related to certain unknown factors. Inter-
estingly, the effects of smoking and alcohol were rendered
insignificant when adjusted for other covariates in logistic
regression, thus suggesting confounding by other varia-
bles.
The awareness regarding renal impairment in our study
population was dismal. This probably reflects on poor
perception of general public and practitioners regarding
the magnitude of CKD in India. In unpublished observa-
tions by Ram Prabhakar et al, less than 20% of general
practitioners could define CKD while less than 12% were
aware of MDRD equation to estimate GFR [39]. This fur-
ther emphasizes the need to increase awareness on CKD
in general public as well as medical fraternity.
The prevalence of proteinuria was 2.25% in the study pop-
ulation. One cross-sectional study from a rural population
in India estimated a lower prevalence (0.47%) [40] while
another cross-sectional study from an urban locale esti-
mated a higher prevalence (4.41%) [3]. Since our study
encompassed all socioeconomic spectra, our prevalence
estimates may be closer to the actual values. The presence
of proteinuria significantly associated with low eGFR.
There was an increasing prevalence of proteinuria as GFR
decreased, thus corroborating proteinuria as a marker of
kidney disease progression. This suggests that subjects
with proteinuria should be worked up adequately for an
underlying renal impairment as proteinuria is a signifi-
cant mortality predictor [41].
Our study has few limitations. The major limitation lies in
using GFR estimating equations not validated for Indian
population. Though CG and MDRD are routinely used in
clinical situations, the accuracy and reliability of these
equations to predict GFR in Indian population is at best
questionable. It is well recognized that Indian population
has a lower normal range of GFR than western popula-
tions [7,42]. This is in part related to anthropometric phe-
notype, low protein intake and possible genetic
endowment with fewer nephrons. Since these equations
were developed from western cohorts, they are more likely
to classify an Indian subject with normal GFR into renal
impairment group. Besides how reliable these equations
are in subjects with normal serum creatinine is also
debated, independent of effects of ethnicity [17,43]. The
application of these equations in epidemiological studies
has also been questioned [44]. It will be interesting to
assess CKD prevalence with a GFR estimating equation
validated for Indian population. A new 'Apollo Chennai
GFR equation' has been proposed but it needs validation
[7]. Another limitation of our study is that we did not cal-
ibrate serum creatinine assays. It is generally accepted that
calibrating serum creatinine assays improves performance
of GFR predicting equations, particularly at higher values
[45]. This also limited us from staging CKD using K/
DOQI guidelines. The use of fasting blood glucose rather
than oral glucose tolerance test may have led to an under-
estimation of true prevalence of diabetes mellitus. Simi-
larly, using a single measure of dipstick proteinuria is
likely to have caused an overestimation especially since
no adjustment for urinary protein concentration was
made. For instance, in a study population in United
States, on a repeat measurement only 63% of subjects
with proteinuria had a positive result [46]. Use of more
specific measures like urine albumin:creatinine ratio
(ACR) to assess micro- and overt albuminuria would be
desirable. Finally, cross-sectional nature of our study does
not allow one to derive a causal inference. Caution must
be exercised in extrapolating this data to determine true
community prevalence in view of these shortcomings.
Conclusion
Our study highlights the emerging issue of CKD in India.
The prevalence of low eGFR in India is similar to many
other tropical nations and with epidemiological transi-
tion to lifestyle disorders, rising prevalence of HTN and
DM and a substantial geriatric population, the situation
has the potential to become a future public health prob-
lem. Increasingly it is being recognized that CKD is an
additional cardiac risk factor and CKD patients are also at
a higher risk of cardiovascular morbidity [47]. Consider-
ing the costs of CKD management, poor CKD awareness
and deficit of trained nephrologists and other health care
professionals, the only viable and cost effective option, at
present, seems to be in primary prevention and screening,
at least for "high risk" groups. We recommend screening
efforts directed at females, elderly and people with low
educational status. In addition, office dipstick detection of
proteinuria can pick up CKD early. Since it is amenable to
early intervention, significantly reducing mortality, sub-
jects with proteinuria should be adequately worked up byBMC Nephrology 2009, 10:4 http://www.biomedcentral.com/1471-2369/10/4
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the primary care provider. Regular follow up has been
shown to benefit subjects with renal impairment [48]. In
view of different racial, dietary and anthropometric pro-
file of South Asians/Indians, studies validating GFR esti-
mating equations derived from Western cohorts are
needed. It will be desirable to have a serum creatinine
based GFR estimating equation validated for South Asian
population through large, multicentric, cohort studies.
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